Directa Plus PLC - graphene nanoplatelets supplier - Notes that Oxfordshire County Council is starting its second trial of a patented asphalt concrete modifier developed by Iterchemica and enhanced by Graphene Plus.
The new trial will see two stretches of Marsh Lane in Oxford resurfaced with different materials, one with GiPave and the other with conventional asphalt to be compared.
"This new trial follows a number of successful trials and pilot schemes in the UK and Italy with the product now gaining considerable traction in construction markets. GiPave is yet another product launching into commercial markets containing our Graphene Plus, a pure form of graphene produced through a sustainable process which is certified safe for humans and the environment," says Chief Executive Officer Giulio Cesareo.
Current stock price: 97.00 pence, down 12%
12-month change: down 18%
By Dayo Laniyan; dayolaniyan@alliancenews.com
Copyright 2022 Alliance News Limited. All Rights Reserved.
Directa Plus (DCTA)